{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-021085","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2025-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.219978+00:00","generated_at":"2026-05-18T00:23:56.884348+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Impact BioMedical to issue 31.9M shares to DSS to settle $12M debt","bullets":["Issued 31,939,778 shares of common stock to DSS Inc. to fully satisfy $12M revolving promissory note from March 2023.","Original note was amended Jan 2024 to extend maturity to Sept 30, 2023, eliminate advance feature, set repayment terms, adjust interest to WSJ Prime + 0.5%.","Shares are freely tradeable and settle all amounts owed under the note and any additional support between June 21, 2025 and closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-021085","json":"https://secwatch.observer/filing/0001641172-25-021085.json","markdown":"https://secwatch.observer/filing/0001641172-25-021085.md","text":"https://secwatch.observer/filing/0001641172-25-021085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000164117225021085/0001641172-25-021085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000164117225021085/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T00:23:56.884348+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}